galactosamine has been researched along with azauridine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keppler, DO | 1 |
| Herrmann, B; Holstege, A; Keppler, DO | 1 |
| Anukarahanonta, T; Gerok, W; Holstege, A; Keppler, D; Pausch, J | 1 |
| Shinozuka, H | 1 |
| Anukarahanonta, T; Holstege, A; Keppler, DO | 1 |
| Beck, G; Giesen, EM; Holstege, A; Keppler, DO | 1 |
| Anderson, LW; Cysyk, RL; Dietrick, DD; Karle, JM | 1 |
7 other study(ies) available for galactosamine and azauridine
| Article | Year |
|---|---|
Uridine triphosphate deficiency, growth inhibition, and death in ascites hepatoma cells induced by a combination of pyrimidine biosynthesis inhibition with uridylate trapping.
Topics: Animals; Azauridine; Carcinoma, Hepatocellular; Cell Division; Cells, Cultured; Female; Galactosamine; Liver Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Pyrimidine Nucleotides; Rats; Time Factors; Transplantation, Homologous; Uracil Nucleotides; Uridine; Uridine Diphosphate Galactose; Uridine Diphosphate Glucose; Uridine Monophosphate | 1977 |
Increased formation of nucleotide derivatives of 5-fluorouridine in hepatoma cells treated with inhibitors of pyrimidine synthesis and D-galactosamine.
Topics: Animals; Azauridine; Biological Transport; Female; Galactosamine; Kinetics; Liver Neoplasms, Experimental; Rats; Ribonucleotides; Uridine | 1978 |
First clinical experiences with a selective chemotherapy of hepatocellular carcinoma with 5-fluorouridine in combination with other antipyrimidines.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azauridine; Carcinoma, Hepatocellular; Female; Galactosamine; Humans; Liver Neoplasms; Male; Middle Aged; Uridine | 1985 |
Ultrastructural study of liver cell injury due to UTP deficiency.
Topics: Animals; Azauridine; Cell Nucleolus; Chemical and Drug Induced Liver Injury; Cytoplasm; Endoplasmic Reticulum; Female; Galactosamine; Galactose; Golgi Apparatus; Injections, Intraperitoneal; Liver; Liver Diseases; Microscopy, Electron; Mitochondria; Rats; Ribosomes; Time Factors; Uracil Nucleotides; Uridine | 1974 |
Selective enhancement of 5-fluorouridine uptake and action in rat hepatomas in vivo following pretreatment with D-galactosamine and 6-azauridine or N-(phosphonacetyl)-L-aspartate.
Topics: Animals; Aspartic Acid; Azauridine; DNA, Neoplasm; Drug Therapy, Combination; Female; Galactosamine; Liver; Liver Neoplasms, Experimental; Organophosphorus Compounds; Phosphonoacetic Acid; Rats; RNA, Neoplasm; Stimulation, Chemical; Uracil Nucleotides; Uridine | 1980 |
Inhibition of tyrosine aminotransferase induction by UTP deficiency and its reversal by 5-fluorouridine in cultured hepatoma cells.
Topics: Animals; Azauridine; Cells, Cultured; Dexamethasone; Enzyme Induction; Galactosamine; Liver Neoplasms, Experimental; Tyrosine Transaminase; Uracil Nucleotides; Uridine; Uridine Triphosphate | 1981 |
Effect of inhibitors of the de novo pyrimidine biosynthetic pathway on serum uridine levels in mice.
Topics: Amides; Animals; Antimetabolites, Antineoplastic; Aspartic Acid; Azauridine; Galactosamine; Liver; Male; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; Pyrazoles; Pyrimidines; Ribonucleosides; Ribose; Uridine | 1981 |